ValiRx plc is listed on AIM of the London Stock Exchange under the ticker code VAL. There are no restrictions on the transfer of ValiRx’s shares and these are not listed on any other exchange.
These disclosures were last reviewed on the 30-11-2020.
- About ValiRx
- Board of directors
- Admission Document & Articles
- Corporate Governance
- Advisors & Bankers
- Annual & Half Yearly Reports
- General Meeting Documentation
- Shareholder Information
- Shares in Issue / AIM Securities Information
- Stock Information
- RNS Announcements
- TR1 Forms and share holdings documents
AIM Securities Information
ValiRx plc is a company incorporated in the United Kingdom under the Companies Act 1985, it’s “principal” place of business is in the United Kingdom.
The Total Number of AIM Securities in issue with nominal value of 0.1p is 64,882,490
The information below was last updated on 30 November 2020.
The percentage of AIM Securities not in public hands is approximately 19.6%.
Our majority shareholder(s)
Shareholder(s) with more than 3%
| Shareholders | Number of Shares | Percentage of Total |
|---|---|---|
| Mr Nicholas Slater (TR1) | 4,306,600 | 6.6% |
| Monecor (London) Ltd | 4,466,969 | 6.9% |
| Mr Adam Hargreaves (TR1) | 3,249,931 | 5.0% |
The Directors’ holding
| Shareholders | Number of Shares | Percentage of Total |
|---|---|---|
| Directors | 732,834 | 1.1% |
Advisors
Corporate Broker
Peterhouse Capital Limited, 80 Cheapside, London, EC2V 6EE
Email: info@peterhousecap.com
Tel: +44 (0) 20 7469 0930
www.peterhousecap.com
Nominated Adviser
Cairn Financial Advisers LLP, Cheyne House, Crown Court, 62-63 Cheapside, London, EC2V 6AX
www.cairnfin.com
Registrars
Neville Registrars Limited, Neville House, Steelpark Road, Halesowen B62 8HD
Email: info@nevilleregistrars.co.uk
Tel: +44 (0) 121585 1131
www.nevilleregistrars.co.uk
Solicitors
DACBeachcroft, 25 Walbrook, London, EC4N 8AF
www.dacbeachcroft.com/en/gb/locations/london-walbrook
Auditors
Adler Shine, Aston House, Cornwall Avenue, Finchley, N3 1LF
Bankers
The Royal Bank of Scotland, Argylle House, 246 Regent Street, London, W1B 3PB
Corporate Governance
The Board of Directors is committed to applying high standards of corporate governance using the guidance of the QCA Code, revised in April 2018 as devised by the Quoted Companies Alliance.
The Corporate Governance sets out ValiRx’s compliance with the ten principles of the QCA Code, displaying how the company complies, and provides links to appropriate disclosures.
These arrangements are also disclosed in our Annual Report and Accounts.
These disclosures were last reviewed on the 30-11-2020.